Eiken Chemical Co., Ltd. (4549) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Eiken Chemical Co., Ltd. (4549:JPX), powered by AI.

Current Price
¥2,658
P/E Ratio
41.0
Market Cap
91.4B
Sector
Healthcare
What is the Eiken Chemical Co., Ltd. stock price forecast?

Eiken Chemical Co., Ltd. is currently trading at ¥2,658. View real-time AI analysis on Alpha Lenz.

What is Eiken Chemical Co., Ltd. insider trading activity?

View the latest insider trading data for Eiken Chemical Co., Ltd. on Alpha Lenz.

What is Eiken Chemical Co., Ltd.'s P/E ratio?

Eiken Chemical Co., Ltd.'s P/E ratio is 41.0.

Eiken Chemical Co., Ltd.

JPX · 4549
¥2,658-42(-1.56%)Market closedJPX regular session 09:00–15:00 JST
Ask about Eiken Chemical Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Eiken Chemical Co., Ltd. trades at a P/E of 41.0 (premium valuation) with modest ROE of 5.0%.

Ask for details

Company Overview

Eiken Chemical Co., Ltd. is a leading Japanese company specializing in the development, production, and marketing of in-vitro diagnostic reagents. Established in 1939, the company plays a crucial role in the healthcare industry by providing essential tools for accurate disease diagnosis and monitoring. Eiken Chemical is renowned for its innovative RUNNER® nucleic acid amplification technology, which has had substantial impacts in the fields of molecular diagnostics and infectious disease detection. Additionally, the company offers a wide range of diagnostic solutions, including reagents for detecting chronic and acute diseases and urinary and blood diagnostic tests. Eiken's products are vital for hospitals, laboratories, and clinics, facilitating timely and accurate patient care. The firm's commitment to research and development ensures the continuous enhancement of its diagnostic tools, reinforcing its market significance. In the financial market, Eiken Chemical Co., Ltd. is valued for its strong foothold in the diagnostic sector and its contribution to advancing medical testing technology in Japan and globally.

CEOMr. Yuji Segawa
SectorHealthcare
IndustryMedical Devices
Employees702

Company Statistics

FY 2025

Profile

¥91,361,060,406Market Cap
¥40,539,000,000Revenue
0.00Shares Out
702Employees

Margins

40.73%Gross
14.23%EBITDA
7.40%Operating
7.38%Pre-Tax
5.50%Net

Valuation

41.01P/E
2.10P/B
2.25EV/Sales
14.90EV/EBITDA
139.48P/FCF

Growth (CAGR)

-1.95%Rev 3Yr
2.07%Rev 5Yr
-29.02%Op Inc 3Yr
-8.28%Op Inc 5Yr
-28.97%Net Inc 3Yr
-8.83%Net Inc 5Yr

Returns

3.59%ROA
4.98%ROE
4.85%ROIC

Financial Health

¥9,873,000,000Cash & Cash Equivalents
¥8,903,000,000Net Debt
43.07%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Eiken Chemical Co., Ltd. (ticker: 4549) is a company listed on JPX in the Healthcare sector (Medical Devices). It has approximately 702 employees. Market cap is $91.4B.

The current price is 2,658 with a P/E ratio of 41.01x and P/B of 2.1x.

ROE is 4.98% and operating margin is 7.40%. Annual revenue is $40.5B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Eiken Chemical Co., Ltd. (4549) Stock Forecast 2026 ¥2,658 — Price, Financials & Analyst Targets | Alpha Lenz